NDC 60505-0564-01 - Brimonidine Tartrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 60505-0564
- Requested NDC
- 60505-0564-01
- Package NDCs from labels
- 60505-0564-1, 60505-0564-2, 60505-0564-3, 60505-0564-01
- Manufacturer
- Apotex Corp. | Apotex Inc.
- Effective date
- 2026-09-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Brimonidine Tartrate - Apotex Corp. | Apotex Inc. | Apotex Corp. | Apotex Inc. | 2026-09-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60505-0564-1 | Brimonidine Tartrate | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 7 | |
| 60505-0564-1 | Brimonidine Tartrate | 5 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 5 | 7 | |
| 60505-0564-2 | Brimonidine Tartrate | 10 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 10 | 7 | |
| 60505-0564-2 | Brimonidine Tartrate | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 7 | |
| 60505-0564-3 | Brimonidine Tartrate | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 7 | |
| 60505-0564-3 | Brimonidine Tartrate | 15 mL in 1 BOTTLE, DROPPER | SOLUTION/ DROPS | 15 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 60505-0564 | BRIMONIDINE TARTRATE SOLUTION/ DROPS [APOTEX CORP.] | 5 | Current NDC, Legacy NDC, 6 package rows | 20240921_64b21e68-610c-5194-ccb2-9d9f6ff8cda9.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 60505-0564-1 | ML - Milliliter | 60505-0564 | 0d0db880-fac8-454f-a7e7-07e3b065126e | 1 | 2022-02-07 |
| 60505-0564-2 | ML - Milliliter | 60505-0564 | 38fedf60-e50e-4633-80bc-070303baf025 | 1 | 2022-02-07 |
| 60505-0564-3 | ML - Milliliter | 60505-0564 | ad0d8326-617a-4cbc-98af-7275fcdb849c | 1 | 2022-02-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chlorode Hypertonicity Ophthalmic Solution | SODIUM CHLORIDE | Rugby Laboratories | 822d25c0-71b3-421d-b702-4cded0c4ca32 | 2026-09-23 | Warnings | 451W47IQ8X |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE ORAL | Saptalis Pharmaceuticals, LLC | 483f338e-a164-4c1f-a34e-fef3312cb7ec | 2026-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| BURBLE | SODIUM CHLORIDE | LETS BURBLE, INC. | 17f48d4f-907c-3829-e063-6394a90ab202 | 2026-09-22 | Warnings | 451W47IQ8X |
| Sterile Water | WATER | B. Braun Medical Inc. | f4284eb6-e553-46d4-90d8-efc80a90a480 | 2026-09-18 | Warnings, Adverse reactions | 059QF0KO0R |
| HEB Saline | NASAL | HEB | 520e20a3-1e16-4cbd-9da3-948747f4f51d | 2026-09-18 | Warnings | 451W47IQ8X |
| Lymph Tonic II | ECHINACEA (ANGUSTIFOLIA), COLLINSONIA CANADENSIS, PHYTOLACCA DECANDRA, KALI IODATUM, PINUS SYLVESTRIS, PIX LIQUIDA, FERRUM PHOSPHORICUM, AESCULUS HIPPOCASTANUM, BARYTA CARBONICA, BERBERIS VULGARIS, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, CAUSTICUM, HEPAR SULPHURIS CALCAREUM, KREOSOTUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, NITRICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA, STELLARIA MEDIA, SULPHUR, TEREBINTHINA, THUJA OCCIDENTALIS, BUFO RANA | BioActive Nutritional, Inc. | 0e3265b0-b210-4a4c-80d2-8a9712981d4e | 2026-09-17 | Warnings | 451W47IQ8X |
| Saline | SALINE | FAMILY DOLLAR SERVICES INC | 7d2acfff-e55b-48b9-9d36-4975563e08ff | 2026-09-17 | Warnings | 451W47IQ8X |
| Potassium chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | c2028705-9e5b-424b-983a-1c7a71dedd74 | 2026-09-16 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9b26cc41-3725-4ef1-afdf-5992816d3b0d | 2026-09-16 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | REMEDYREPACK INC. | d1e55181-6f85-42c9-922c-808494b6399a | 2026-09-15 | Warnings, Adverse reactions | 660YQ98I10 |
| FlyLeaf RINGWORM TREATMENT | MICONAZOLE NITRATE 2% | Guangzhou Huixue Biotechnology Co., Ltd. | 5b597a3b-b5ff-2246-e063-6394a90a1046 | 2026-09-13 | Warnings | 059QF0KO0R |
| calcium chloride | CALCIUM CHLORIDE | Eskayef Pharmaceuticals Limited | 5b0bd762-4c87-597e-e063-6394a90a8303 | 2026-09-09 | Warnings, Adverse reactions | M4I0D6VV5M |
| TheraTears | CARBOXYMETHYLCELLULOSE SODIUM | MEDTECH PRODUCTS INC | 17a01236-130f-495b-9f8d-92b6a23b2dc5 | 2026-09-09 | Warnings | K679OBS311 |
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | REMEDYREPACK INC. | ace1eb11-b925-405a-b772-58c60b3ca7d4 | 2026-09-09 | Warnings, Adverse reactions | 660YQ98I10 |
| Saline | NASAL | Raritan Pharmaceuiticals Inc | 4b178e4e-a10f-4b75-8140-1f7548e203ad | 2026-09-09 | Warnings | 451W47IQ8X |
| Brimonidine Tartrate | BRIMONIDINE TARTRATE | Apotex Corp. | e08a915a-77ca-4d16-d760-11b05848418d | 2026-09-09 | Warnings, Adverse reactions | 4S9CL2DY2H |
| Thyroid Support | CALCAREA CARBONICA, CALCAREA IODATA, CAUSTICUM, FERRUM IODATUM, FUCUS VESICULOSUS, KALI IODATUM, NATRUM MURIATICUM, THYROIDINUM (BOVINE) | NaturalCare | 07b4e0ed-2b00-4d0a-ad8f-fc6deff15325 | 2026-09-08 | Warnings | 451W47IQ8X |
| Nerve Guard Nerve Relief | LIDOCAINE HYDROCHLORIDE, MENTHOL,MAGNESIUM CHLORIDE | Micelle Laboratories, Incorporated | 6b78f40f-2a7f-4c49-96af-1a95acbf430f | 2026-09-04 | Warnings | 02F3473H9O |
| Psoriasis Control | CENTELLA ASIATICA, SODIUM CHLORIDE, AND SILICON DIOXIDE | Forces of Nature | 2db33771-0bb9-49f8-84fa-dddc28e4ba26 | 2026-09-04 | Warnings | 451W47IQ8X |
| Brimonidine Tartrate Ophthalmic Solution | BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION | Lifestar Pharma LLC | f6666d85-f810-4869-993d-e8ae35b4517f | 2026-09-03 | Warnings, Adverse reactions | 4S9CL2DY2H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.